FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109583172> ?p ?o ?g. }

• W2109583172 endingPage "471" @default.
• W2109583172 startingPage "466" @default.
• W2109583172 abstract "There is limited information in the primary literature regarding the relationship of medication adherence to attainment of glycosylated hemoglobin A1c (A1c) goals. The 2 oral antihyperglycemic medications, sulfonylurea and/or metformin, were chosen for retrospective analysis because they are the 2 most common oral medications used by patients with diabetes.To describe the relationship between adherence with 1 or both of 2 oral antihyperglycemic medications (sulfonylurea and metformin) and A1c goal attainment for health maintenance organization (HMO) patients enrolled in a diabetes disease management program.This was a retrospective, descriptive evaluation of patients enrolled in a managed care diabetes disease management program in a 188,000-member independent practice association model HMO located in the Southeast. The dataset in this analysis contained demographic, enrollment, pharmacy claims, and clinical laboratory data. Continuously enrolled patients were included if there was a documented A1c value obtained at least 90 days after the initial oral antihyperglycemic medication (sulfonylurea or metformin) prescription index date. The medication possession ratio (MPR) was calculated from the pharmacy claim records and correlated with the A1c value.A total of 42% of patients on sulfonylurea therapy and 46% of those on metformin reached an A1c goal of < or = 7.0%. For patients taking a sulfonylurea, the mean MPR for those who reached the predetermined A1c goal (< or = 7.0) was 0.82 (0.29) compared with 0.72 (0.31) for those patients who did not reach the A1c target goal (P < 0.001). For patients taking metformin, the mean MPR for those who reached the predetermined A1c goal was 0.77 (0.3) versus 0.62 (0.3) for those patients who did not reach the A1c target goal (P < 0.001). A Pearson correlation analysis revealed a positive relationship between the MPR and A1c for sulfonylurea (r = -0.295, P < 0.001) and for metformin (r = -0.285, P < 0.001). For those patients taking both sulfonylurea and metformin, the Pearson correlation analysis showed a positive relationship between the 2 MPRs (r = 0.65, P < 0.001).Medication adherence as measured by the MPR was higher for patients taking a sulfonylurea or metformin who reached the target A1c goal of d7.0% compared with patients taking these drugs who did not reach the target A1c goal." @default.
• W2109583172 created "2016-06-24" @default.
• W2109583172 creator A5013073176 @default.
• W2109583172 creator A5019440500 @default.
• W2109583172 creator A5026312336 @default.
• W2109583172 creator A5033840092 @default.
• W2109583172 creator A5048294207 @default.
• W2109583172 date "2006-07-01" @default.
• W2109583172 modified "2023-10-12" @default.
• W2109583172 title "Relationship of Oral Antihyperglycemic (Sulfonylurea or Metformin) Medication Adherence and Hemoglobin A1c Goal Attainment for HMO Patients Enrolled in a Diabetes Disease Management Program" @default.
• W2109583172 cites W139680375 @default.
• W2109583172 cites W1967813980 @default.
• W2109583172 cites W1970190475 @default.
• W2109583172 cites W1985288472 @default.
• W2109583172 cites W2048207206 @default.
• W2109583172 cites W2059158127 @default.
• W2109583172 cites W2059764669 @default.
• W2109583172 cites W2068733872 @default.
• W2109583172 cites W2069024810 @default.
• W2109583172 cites W2078089300 @default.
• W2109583172 cites W2113893668 @default.
• W2109583172 cites W2120627572 @default.
• W2109583172 cites W2137665561 @default.
• W2109583172 cites W2143331672 @default.
• W2109583172 cites W2144002425 @default.
• W2109583172 cites W2145355470 @default.
• W2109583172 cites W2148382332 @default.
• W2109583172 cites W2164733897 @default.
• W2109583172 cites W2172241785 @default.
• W2109583172 cites W2182142554 @default.
• W2109583172 cites W2276979705 @default.
• W2109583172 cites W2337454357 @default.
• W2109583172 cites W2769264260 @default.
• W2109583172 cites W45037547 @default.
• W2109583172 cites W2183034255 @default.
• W2109583172 cites W2398352823 @default.
• W2109583172 doi "https://doi.org/10.18553/jmcp.2006.12.6.466" @default.
• W2109583172 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16925454" @default.
• W2109583172 hasPublicationYear "2006" @default.
• W2109583172 type Work @default.
• W2109583172 sameAs 2109583172 @default.
• W2109583172 citedByCount "88" @default.
• W2109583172 countsByYear W21095831722012 @default.
• W2109583172 countsByYear W21095831722013 @default.
• W2109583172 countsByYear W21095831722014 @default.
• W2109583172 countsByYear W21095831722015 @default.
• W2109583172 countsByYear W21095831722016 @default.
• W2109583172 countsByYear W21095831722017 @default.
• W2109583172 countsByYear W21095831722018 @default.
• W2109583172 countsByYear W21095831722019 @default.
• W2109583172 countsByYear W21095831722020 @default.
• W2109583172 countsByYear W21095831722022 @default.
• W2109583172 countsByYear W21095831722023 @default.
• W2109583172 crossrefType "journal-article" @default.
• W2109583172 hasAuthorship W2109583172A5013073176 @default.
• W2109583172 hasAuthorship W2109583172A5019440500 @default.
• W2109583172 hasAuthorship W2109583172A5026312336 @default.
• W2109583172 hasAuthorship W2109583172A5033840092 @default.
• W2109583172 hasAuthorship W2109583172A5048294207 @default.
• W2109583172 hasConcept C104863432 @default.
• W2109583172 hasConcept C126322002 @default.
• W2109583172 hasConcept C134018914 @default.
• W2109583172 hasConcept C167135981 @default.
• W2109583172 hasConcept C2426938 @default.
• W2109583172 hasConcept C2776217022 @default.
• W2109583172 hasConcept C2777180221 @default.
• W2109583172 hasConcept C2778854520 @default.
• W2109583172 hasConcept C2780323712 @default.
• W2109583172 hasConcept C512399662 @default.
• W2109583172 hasConcept C555293320 @default.
• W2109583172 hasConcept C71924100 @default.
• W2109583172 hasConcept C98274493 @default.
• W2109583172 hasConceptScore W2109583172C104863432 @default.
• W2109583172 hasConceptScore W2109583172C126322002 @default.
• W2109583172 hasConceptScore W2109583172C134018914 @default.
• W2109583172 hasConceptScore W2109583172C167135981 @default.
• W2109583172 hasConceptScore W2109583172C2426938 @default.
• W2109583172 hasConceptScore W2109583172C2776217022 @default.
• W2109583172 hasConceptScore W2109583172C2777180221 @default.
• W2109583172 hasConceptScore W2109583172C2778854520 @default.
• W2109583172 hasConceptScore W2109583172C2780323712 @default.
• W2109583172 hasConceptScore W2109583172C512399662 @default.
• W2109583172 hasConceptScore W2109583172C555293320 @default.
• W2109583172 hasConceptScore W2109583172C71924100 @default.
• W2109583172 hasConceptScore W2109583172C98274493 @default.
• W2109583172 hasIssue "6" @default.
• W2109583172 hasLocation W21095831721 @default.
• W2109583172 hasLocation W21095831722 @default.
• W2109583172 hasOpenAccess W2109583172 @default.
• W2109583172 hasPrimaryLocation W21095831721 @default.
• W2109583172 hasRelatedWork W2072752555 @default.
• W2109583172 hasRelatedWork W2121382942 @default.
• W2109583172 hasRelatedWork W2319523397 @default.
• W2109583172 hasRelatedWork W2326091077 @default.
• W2109583172 hasRelatedWork W2417464647 @default.
• W2109583172 hasRelatedWork W2419371745 @default.
• W2109583172 hasRelatedWork W2965764969 @default.
• W2109583172 hasRelatedWork W3111487352 @default.

• next